UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056211
Receipt number R000064225
Scientific Title Sleep evaluation using an electroencephalograph while using earplug-type products at home
Date of disclosure of the study information 2024/11/20
Last modified on 2024/11/20 13:36:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Sleep evaluation using an electroencephalograph while using earplug-type products at home

Acronym

Sleep evaluation using an electroencephalograph while using earplug-type products at home

Scientific Title

Sleep evaluation using an electroencephalograph while using earplug-type products at home

Scientific Title:Acronym

Sleep evaluation using an electroencephalograph while using earplug-type products at home

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effect of earplug heating on sleep quality

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Sleep measurement data

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

Sleeping with heat-generating earplugs

Sleeping with non-heating earplugs

Interventions/Control_2

Sleeping with non-heating earplugs on

Sleeping with heating earplugs on

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

55 years-old >=

Gender

Male and Female

Key inclusion criteria

Those aged 20 years or older and 55 years or younger at the time of obtaining consent
Those who are dissatisfied with their sleep
Those who sleep in bed every day
Those who can sleep alone during the study period
Those who have received an explanation of the study and have fully understood it before participating, and have given written consent
PSQI (Pittsburgh Sleep Quality Index): 4-8 points
STAI (Trait Anxiety Scale): trait anxiety 33-55 points

Key exclusion criteria

BMI less than 18.5 or 30.0 or more
Those with symptoms of sleep apnea syndrome or diagnosed with a sleep disorder
Those who wish to participate in the following activities on the day of the study and during the study period
Drinking alcohol Excessive exercise Caffeine intake after 6 p.m. Smoking
Those who regularly use any medicine or use medical devices
Those who are primarily responsible for childcare or elderly care
Those who live with or keep pets
Those who have used the test product in the past and experienced some abnormality when using it
Those with ear disorders
Those who are deemed inappropriate by the research staff

Target sample size

14


Research contact person

Name of lead principal investigator

1st name Ryui
Middle name
Last name Kiyoe

Organization

Kobayashi Pharmaceutical Co., Ltd.

Division name

Household Products Division Wellness Care R&D Group

Zip code

567-0057

Address

1-30-3,Toyokawa, Ibaraki-city, Osaka, Japan

TEL

080-3452-9751

Email

r.kiyoe@kobayashi.co.jp


Public contact

Name of contact person

1st name Miyu
Middle name
Last name Okano

Organization

Kobayashi Pharmaceutical Co., Ltd.

Division name

Household Products Division Wellness Care R&D Group

Zip code

567-0057

Address

1-30-3,Toyokawa, Ibaraki-city, Osaka, Japan

TEL

08091231774

Homepage URL


Email

mi.okano@kobayashi.co.jp


Sponsor or person

Institute

Kobayashi Pharmaceutical Co., Ltd.
Household Products Division Wellness Care R&D Group

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

ASMARQ Co., Ltd.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiba Palace Clinic Ethics Review Committee

Address

DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

Tel

03-5408-1599

Email

shiba_palace@s-palace-clinic.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 11 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 11 Month 12 Day

Date of IRB

2024 Year 11 Month 14 Day

Anticipated trial start date

2024 Year 11 Month 20 Day

Last follow-up date

2024 Year 12 Month 20 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 11 Month 20 Day

Last modified on

2024 Year 11 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064225